| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $76,400 | 1 | 50 |
Sells | $9,404 | 1 | 50 |
| Solomon Ryan | Chief Financial Officer | 1 | $76,400 | 0 | $0 | $76,400 |
| McQuiddy Collin | Chief Accounting Officer | 0 | $0 | 1 | $9,404 | $-9,404 |
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Over the last 12 months, insiders at Enhabit, Inc. have bought $76,400 and sold $9,404 worth of Enhabit, Inc. stock.
On average, over the past 5 years, insiders at Enhabit, Inc. have bought $523,455 and sold $7,495 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Solomon Ryan (Chief Financial Officer) — $76,400.
The last purchase of 10,000 shares for transaction amount of $76,400 was made by Solomon Ryan (Chief Financial Officer) on 2025‑08‑08.
| 2025-08-08 | Solomon Ryan | Chief Financial Officer | 10,000 0.0198% | $7.64 | $76,400 | +9.71% | ||
| 2025-03-10 | Sale | McQuiddy Collin | Chief Accounting Officer | 1,096 0.0022% | $8.58 | $9,404 | -2.83% | |
| 2024-12-12 | Bolton Jeffrey | director | 4,000 0.0081% | $8.69 | $34,760 | -4.69% | ||
| 2024-12-10 | MCGUIGAN STUART M | director | 15,000 0.0306% | $8.81 | $132,150 | -5.47% | ||
| 2024-11-12 | Bolton Jeffrey | director | 3,000 0.006% | $7.60 | $22,800 | +5.91% | ||
| 2024-11-08 | Bolton Jeffrey | director | 7,000 0.0139% | $7.77 | $54,377 | +2.15% | ||
| 2024-08-22 | Bolton Jeffrey | director | 5,000 0.0099% | $8.01 | $40,050 | -0.56% | ||
| 2024-08-09 | Bolton Jeffrey | director | 5,000 0.0098% | $8.29 | $41,450 | -5.44% | ||
| 2024-08-08 | Bolton Jeffrey | director | 2,000 0.004% | $8.60 | $17,200 | -6.10% | ||
| 2024-05-17 | Bolton Jeffrey | director | 10,000 0.0193% | $8.33 | $83,300 | -0.12% | ||
| 2024-05-14 | Hoeflinger Erin | director | 2,000 0.004% | $9.00 | $18,000 | -8.79% | ||
| 2024-05-10 | Bolton Jeffrey | director | 10,000 0.0197% | $8.24 | $82,400 | -1.20% | ||
| 2024-03-01 | Sale | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 634 0.0013% | $8.81 | $5,586 | -4.20% | |
| 2023-05-26 | Bolton Jeffrey | director | 2,000 0.004% | $11.61 | $23,220 | -7.53% | ||
| 2023-05-22 | SHAW L EDWARD JR | director | 10,000 0.0198% | $11.98 | $119,800 | -12.00% | ||
| 2023-05-18 | Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 10,000 0.02% | $11.99 | $119,900 | -10.49% | ||
| 2023-05-18 | Hoeflinger Erin | director | 2,100 0.0042% | $11.82 | $24,822 | -10.49% | ||
| 2023-05-17 | Bolton Jeffrey | director | 2,000 0.0039% | $11.80 | $23,600 | -10.64% | ||
| 2022-11-18 | Bolton Jeffrey | director | 1,000 0.002% | $12.69 | $12,690 | -0.82% | ||
| 2022-11-09 | Bolton Jeffrey | director | 2,000 0.004% | $12.75 | $25,500 | +0.08% |
| Solomon Ryan | Chief Financial Officer | 193468 0.3817% | $2.18M | 1 | 0 | |
| McQuiddy Collin | Chief Accounting Officer | 0 0% | $0 | 0 | 1 | |
| Jacobsmeyer Barbara Ann | President and CEO | 238442 0.4704% | $2.69M | 1 | 0 | +3.36% |
| Bolton Jeffrey | director | 98144 0.1936% | $1.11M | 14 | 0 | <0.0001% |
| Langham Ronald Leroy JR | EVP Clinical Excel. & Strategy | 57164 0.1128% | $644,524.10 | 1 | 1 | <0.0001% |
| MCGUIGAN STUART M | director | 46810 0.0923% | $527,782.75 | 1 | 0 | <0.0001% |
| SHAW L EDWARD JR | director | 38989 0.0769% | $439,600.98 | 2 | 0 | <0.0001% |
| Hoeflinger Erin | director | 30399 0.06% | $342,748.73 | 3 | 0 | <0.0001% |
| LaMonica Susan | 23095 0.0456% | $260,396.13 | 1 | 0 | +8.59% | |
| ELSON CHARLES M | 22069 0.0435% | $248,827.98 | 1 | 0 | <0.0001% | |
| CURL YVONNE M | 17608 0.0347% | $198,530.20 | 1 | 0 | +0.3% | |
| MAUPIN JOHN E JR D D S | 17390 0.0343% | $196,072.25 | 1 | 0 | +0.3% | |
| Rush Gregory S | director | 16597 0.0327% | $187,131.18 | 2 | 0 | <0.0001% |
| Brown-Stevenson Tina L. | 9645 0.019% | $108,747.38 | 1 | 0 | <0.0001% | |
| HIGDON LEO I JR | director | 7926 0.0156% | $89,365.65 | 3 | 0 | +2.32% |
| Marion Tanya Renee | Chief Human Resources Officer | 1712 0.0034% | $19,302.80 | 1 | 0 | <0.0001% |
| Increased Positions | 65 | +29.82% | 4M | +7.75% |
| Decreased Positions | 93 | -42.66% | 7M | -13.12% |
| New Positions | 19 | New | 1M | New |
| Sold Out Positions | 27 | Sold Out | 3M | Sold Out |
| Total Postitions | 190 | -12.84% | 49M | -5.36% |
| Deerfield Management Company, L.P. | $43,157.00 | 9.31% | 4.75M | -32,118 | -0.67% | 2025-09-30 |
| 8 Knots Management, Llc | $38,349.00 | 8.27% | 4.22M | +365,779 | +9.49% | 2025-09-30 |
| Blackrock, Inc. | $36,133.00 | 7.79% | 3.98M | +87,801 | +2.26% | 2025-09-30 |
| Vanguard Group Inc | $30,843.00 | 6.65% | 3.39M | +256,559 | +8.18% | 2025-09-30 |
| Ubs Group Ag | $28,479.00 | 6.14% | 3.13M | -210,736 | -6.3% | 2025-09-30 |
| Arex Capital Management, Lp | $22,625.00 | 4.88% | 2.49M | +6,490 | +0.26% | 2025-09-30 |
| Jana Partners Management, Lp | $19,427.00 | 4.19% | 2.14M | 0 | 0% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $17,999.00 | 3.88% | 1.98M | -59,663 | -2.92% | 2025-09-30 |
| Systematic Financial Management Lp | $17,617.00 | 3.8% | 1.94M | -3,392 | -0.17% | 2025-09-30 |
| Paradice Investment Management Llc | $15,789.00 | 3.41% | 1.74M | 0 | 0% | 2025-09-30 |